Related Experiment Video
Updated: Jul 7, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
[How to deal with elevated gradient following TAVR?]
Emmanuel Gall1, Hakim Benamer2, Dominique Fourchy2
1Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, 91300, Massy, France; Université Paris-Cité, Department of Cardiology, University Hospital of Lariboisiere, (Assistance Publique des Hôpitaux de Paris, AP-HP), 75010, Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisiere, 75010, Paris, France; MIRACL.ai laboratory, Multimodality Imaging for Research and Artificial Intelligence Core Laboratory, University Hospital of Lariboisiere (AP-HP), 75010, Paris, France.
Transcatheter aortic valve implantation (TAVI) is effective for aortic stenosis. This study details diagnosing and managing increased transvalvular gradients, a form of secondary transcatheter heart valve dysfunction, after TAVI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Transcatheter aortic valve implantation (TAVI) is a primary treatment for severe aortic stenosis.
- Expanding TAVI indications necessitate durable transcatheter heart valve (THV) function.
- Secondary THV dysfunction, indicated by elevated transvalvular gradients, requires careful evaluation.
Purpose of the Study:
- To outline diagnostic strategies for secondary transvalvular gradient elevation post-TAVI.
- To present management approaches for diverse causes of secondary THV dysfunction.
- To illustrate clinical decision-making through case studies.
Main Methods:
- Review of TAVI outcomes and secondary THV dysfunction mechanisms.
- Application of VARC-3 criteria for classifying THV dysfunction.
- Case-based illustration of diagnostic workup and treatment selection.
Main Results:
- Secondary THV dysfunction presents with increased transvalvular gradients.
- Common causes include structural valve deterioration, non-structural dysfunction, thrombosis, and endocarditis.
- Systematic diagnosis is key to effective management.
Conclusions:
- Understanding the mechanisms of secondary THV dysfunction is crucial for TAVI success.
- Prompt and accurate diagnosis leads to appropriate management strategies.
- Ensuring THV longevity is vital with expanding TAVI use in lower-risk patients.
More Related Videos
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management

